NCT05431686View on ClinicalTrials.gov

Group Visits for High Risk Type 1 Diabetes (T1D)

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 16, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Type 1 Diabetes
Interventions
BEHAVIORAL

SMA visits

SMA visit once every 3 months over a 12 month period

Trial Locations (1)

20010

RECRUITING

Children's National Hospital, Washington D.C.

Sponsors
All Listed Sponsors
collaborator

American Diabetes Association

OTHER

collaborator

DexCom, Inc.

INDUSTRY

lead

Children's National Research Institute

OTHER

NCT05431686 - Group Visits for High Risk Type 1 Diabetes (T1D) | Biotech Hunter | Biotech Hunter